These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31572453)

  • 21. The Pleiotropic Function of Human Sirtuins as Modulators of Metabolic Pathways and Viral Infections.
    Alqarni MH; Foudah AI; Muharram MM; Labrou NE
    Cells; 2021 Feb; 10(2):. PubMed ID: 33669990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial Sirtuins in Chronic Degenerative Diseases: New Metabolic Targets in Colorectal Cancer.
    Colloca A; Balestrieri A; Anastasio C; Balestrieri ML; D'Onofrio N
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification.
    Lin S; Du J; Hao J; Luo X; Wu H; Zhang H; Zhao X; Xu L; Wang B
    Cancer Manag Res; 2021; 13():8611-8627. PubMed ID: 34815715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of enhancer of zeste homolog 2 in cisplatin-resistance in ovarian cancer cells by interacting with several genes.
    Wang H; Yu Y; Chen C; Wang Q; Huang T; Hong F; Zhu L
    Mol Med Rep; 2015 Aug; 12(2):2503-10. PubMed ID: 25955318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
    Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
    J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Research progress on Sirtuins (SIRTs) family modulators.
    Chen M; Tan J; Jin Z; Jiang T; Wu J; Yu X
    Biomed Pharmacother; 2024 May; 174():116481. PubMed ID: 38522239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.
    Huang YL; Ning G; Chen LB; Lian YF; Gu YR; Wang JL; Chen DM; Wei H; Huang YH
    Cancer Manag Res; 2019; 11():1725-1740. PubMed ID: 30863181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments.
    Gao L; Li X; Guo Q; Nie X; Hao Y; Liu Q; Liu J; Zhu L; Yan L; Lin B
    Cancer Cell Int; 2020; 20():509. PubMed ID: 33088217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of sirtuins with clinicopathological parameters and overall survival in gastric cancer.
    Shen X; Li P; Xu Y; Chen X; Sun H; Zhao Y; Liu M; Zhang W
    Oncotarget; 2017 Sep; 8(43):74359-74370. PubMed ID: 29088792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinctive Roles of Sirtuins on Diabetes, Protective or Detrimental?
    Song J; Yang B; Jia X; Li M; Tan W; Ma S; Shi X; Feng L
    Front Endocrinol (Lausanne); 2018; 9():724. PubMed ID: 30559718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive genomic and prognostic analysis of the IL‑17 family genes in lung cancer.
    Liao T; Fan J; Lv Z; Xu J; Wu F; Yang G; Huang Q; Guo M; Hu G; Zhou M; Duan L; Wang S; Jin Y
    Mol Med Rep; 2019 Jun; 19(6):4906-4918. PubMed ID: 31059089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SIRT5 downregulation is associated with poor prognosis in glioblastoma.
    Chen X; Xu Z; Zeng S; Wang X; Liu W; Qian L; Wei J; Yang X; Shen Q; Gong Z; Yan Y
    Cancer Biomark; 2019; 24(4):449-459. PubMed ID: 30909186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of sirtuins with clinicopathological parameters and prognosis in non-small cell lung cancer.
    Gong J; Wang H; Lou W; Wang G; Tao H; Wen H; Liu Y; Xie Q
    Cancer Manag Res; 2018; 10():3341-3356. PubMed ID: 30237737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Potential Therapeutic Target for E2F1 and Prognostic Factors of E2F1/2/3/5/7/8 in Human Gastric Cancer.
    Liu X; Hu C
    Mol Ther Methods Clin Dev; 2020 Sep; 18():824-838. PubMed ID: 32953933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AKR1C1-3, notably AKR1C3, are distinct biomarkers for liver cancer diagnosis and prognosis: Database mining in malignancies.
    Zhao SF; Wang SG; Zhao ZY; Li WL
    Oncol Lett; 2019 Nov; 18(5):4515-4522. PubMed ID: 31611960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirtuins as Players in the Signal Transduction of
    Lombardo GE; Russo C; Maugeri A; Navarra M
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.